Imipenem

This classification denotes a beta-lactam antibiotic with the molecular formula C12H17N3O4S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 71OTZ9ZE0A, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5r-(5-alpha,6-alpha(r*)))- but generally known as imipenem, which bears US NIH Compound Identifier 47317. European Medicines Agency schedules Imipenem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08151MIG. IMIPENEM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule imipenem under HS 29419000 and SITC 54139. As of Q4 2014, IMIPENEM remains the US FDA Preferred Term for this commodity. Imipenem bears US NLM identifiers UMLS ID C0020933 and NCI Concept Code C570. SMILES: CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O.